Antihistamines offer new hope for erythropoietic protoporphyria-related liver disease

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

Chlorcyclizine shows promise in reducing protoporphyrin-IX accumulation and liver damage in erythropoietic protoporphyria, targeting histamine pathways.